Comparison of the Binding Activities of Some Drugs on α 2A , α 2B and α 2C ‐Adrenoceptors and Non‐Adrenergic Imidazoline Sites in the Guinea Pig
Abstract
Abstract: Simultaneous computer modelling of control and guanfacine‐masked [ 3 H]‐MK 912 saturation curves as well as guanfacine competition curves revealed that both α 2A ‐ and α 2C ‐adrenoceptor subtypes were present in the guinea pig cerebral cortex. The K d value of [ 3 H]‐MK 912 determined for the α 2A ‐subtype was 403 pM and for the α 2C ‐subtype 79.8 pM; the receptor sites showing capacities 172 and 19.5 fmol/mg protein, respectively. The K ds of guanfacine were 20 and 880 nM for the α 2A ‐ and α 2C ‐adrenoceptor, respectively. In the guinea pig kidney [ 3 H]‐MK 912 bound to a single saturable site with K d 8.34 nM and capacity 285 fmol/mg protein, the site showing pharmacological properties like an α 2B ‐adrenoceptor. Binding constants of 22 compounds for the three guinea pig α 2 ‐adrenoceptor subtypes were determined by computer modelling competition curves using for the cerebral cortex a “3‐curve assay”, for the kidney an “1‐curve assay”, and using [ 3 H]‐MK 912 as labelled ligand. Of the tested drugs guanfacine and BRL 44408 were found to be clearly α 2A ‐selective. Spiroxatrine, yohimbine, rauwolscine and WB 4101, as well as [ 3 H]‐MK 912 itself, were found to be α 2C ‐selective. The most selective compounds for α 2B ‐adrenoceptors, when compared to α 2A ‐adrenoceptors, were ARC 239 and prazosin. In the guinea pig kidney [ 3 H]‐p‐aminoclonidine bound to α 2 ‐adrenoceptors as well as to non‐adrenergic imidazoline sites. The α 2 ‐adrenoceptors could be completely blocked using 10 μM (‐)‐adrenaline without the non‐adrenergic sites being affected. During these conditions the analysis of combined saturation and competition studies using labelled and unlabeled p‐aminoclonidine with computer modelling revealed that the ligand labelled two different sites with K ds of 310 and 47,000 nM, respectively. Competition curves of 16 compounds for the non‐adrenergic [ 3 H]‐p‐aminoclonidine sites were shallow and resolved into two‐site fits. For the high affinity [ 3 H]‐p‐aminoclonidine site the highest affinities were shown by 1‐medetomidine, UK‐14,304, guanabenz and detomidine; the K ds of these drugs ranging 26–72 nM. All drugs tested showed low but varying affinities for the low affinity [ 3 H]‐p‐aminoclonidine site. These data indicated that the [ 3 H]‐p‐aminoclonidine binding sites of the guinea pig kidney are grossly different from the [ 3 H]‐idazoxan binding I 2 ‐receptors previously demonstrated also to be present in the guinea pig kidney.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Guanfacine is the most selective α2A-adrenoceptor agonist currently available, with higher affinity for the α2A- than for the α2B- or α2C-adrenoceptor subtypes.
“Guanfacine is the most selective α2A-adrenoceptor agonist currently available, with higher affinity for the α2A- than for the α2B- or α2C-adrenoceptor subtypes (Uhlén et al., 1995; Uhlen and Wikberg, 1991)”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Uhlén et al., 1995
Cited by
Sorted by citations
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · see citing works
Arnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383 · see citing works
Guanfacine treatment of cognitive impairment in schizophrenia
Friedman, J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00249-4 · Cited by 113 · see citing works
Dopamine D2 Receptor Modulation of Human Response Inhibition and Error Awareness
Nandam, L. S., Hester, R., Wagner, J., Dean, A. J., Messer, C., Honeysett, A., Nathan, P. J., & Bellgrove, M. A. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00327 · Cited by 50 · see citing works
Mathai, D. S., Holst, M., Rodgman, C., Haile, C. N., Keller, J., Hussain, M. Z., Kosten, T. R., Newton, T. F., & Verrico, C. D. (2018) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.16120328 · Cited by 12 · see citing works
- Authors
- Uhlén, S., Muceniece, R., Rangel, N., Tiger, G., & Wikberg, J. E. S.
- Affiliations
- Umeå University (SE)
- Corresponding author
- Uhlén, Staffan
- Venue
- Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 76
- Issue
- 6
- Pages
- 353-364
- ISSN
- 0901-9928 (ISSN-L)
- OpenAlex
- W2092470701
- Cited by
- 59
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2019: 4 · 2018: 1 · 2017: 4 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- alpha2-adrenoceptors, imidazoline receptors, guanfacine, BRL 44408, receptor selectivity, competitive binding, saturation binding
- MeSH terms
- Adrenergic alpha-Antagonists, Animals, Binding Sites, Cerebral Cortex, Clonidine, Guinea Pigs, Imidazoles, Kidney, Quinolizines, Receptors, Drug, Receptors, Adrenergic, alpha-2, Rats, Imidazoline Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review